miR-1284, miR-129-5p and miR-1271‐5p can also downregulate ZIC2 expression in breast cancer, prostate cancer, cervical cancer, acute myeloid leukemia and liver cancer, respectively 25-29. Here, ZIC2 is linked to breast carcinoma.